Cargando…

PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson’s Disease

Parkinson’s disease (PD) is an age-related neurodegenerative disorder affecting millions of people worldwide. The disease is characterized by the progressive loss of dopaminergic neurons and spread of Lewy pathology (α-synuclein aggregates) in the brain but the pathogenesis remains elusive. PD prese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wen, Fu, YuHong, Halliday, Glenda M., Sue, Carolyn M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291125/ https://www.ncbi.nlm.nih.gov/pubmed/34295884 http://dx.doi.org/10.3389/fcell.2021.612476

Ejemplares similares

The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
por: Minakaki, Georgia, et al.
Publicado: (2020)

Linking Alpha-Synuclein to the Actin Cytoskeleton: Consequences to Neuronal Function
por: Oliveira da Silva, Marina I., et al.
Publicado: (2020)

Parkinson’s Disease: A Nanotheranostic Approach Targeting Alpha-Synuclein Aggregation
por: Zoey, Fong LaiGuan, et al.
Publicado: (2021)

Alpha Synuclein Connects the Gut-Brain Axis in Parkinson’s Disease Patients – A View on Clinical Aspects, Cellular Pathology and Analytical Methodology
por: Schaeffer, Eva, et al.
Publicado: (2020)

Mitochondrial Respiratory Chain Dysfunction—A Hallmark Pathology of Idiopathic Parkinson’s Disease?
por: Flønes, Irene H., et al.
Publicado: (2022)

Toll-like receptor 2 is increased in neurons in Parkinson’s disease brain and may contribute to alpha-synuclein pathology
por: Dzamko, Nicolas, et al.
Publicado: (2016)

Alpha-Synuclein Pathology Coincides With Increased Number of Early Stage Neural Progenitors in the Adult Hippocampus
por: Bender, Hannah, et al.
Publicado: (2021)

Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation
por: Huang, Yue, et al.
Publicado: (2012)

Aberrant Expression of Circulating MicroRNA Leads to the Dysregulation of Alpha-Synuclein and Other Pathogenic Genes in Parkinson’s Disease
por: Cai, Meng, et al.
Publicado: (2021)

Intracellular Alpha-Synuclein and Immune Cell Function
por: Grozdanov, Veselin, et al.
Publicado: (2020)

Reversal of Alpha-Synuclein Fibrillization by Protein Disulfide Isomerase
por: Serrano, Albert, et al.
Publicado: (2020)

Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease?
por: Bantle, Collin M., et al.
Publicado: (2021)

“Janus-Faced” α-Synuclein: Role in Parkinson’s Disease
por: Ray, Bipul, et al.
Publicado: (2021)

Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease: The Emerging Role of VDAC
por: Risiglione, Pierpaolo, et al.
Publicado: (2021)

GBA-Associated Synucleinopathies: Prime Candidates for Alpha-Synuclein Targeting Compounds
por: Brockmann, Kathrin
Publicado: (2020)

Alpha-Synuclein and LRRK2 in Synaptic Autophagy: Linking Early Dysfunction to Late-Stage Pathology in Parkinson’s Disease
por: Lamonaca, Giulia, et al.
Publicado: (2020)

Current Evidence for a Bidirectional Loop Between the Lysosome and Alpha-Synuclein Proteoforms
por: Wildburger, Norelle C., et al.
Publicado: (2020)

Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease
por: Guo, Mengyuan, et al.
Publicado: (2022)

Editorial: Molecular Links Between Mitochondrial Damage and Parkinson's Disease and Related Disorders
por: Imai, Yuzuru, et al.
Publicado: (2021)

Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson’s Disease Patients
por: Youssef, Priscilla, et al.
Publicado: (2021)

Alpha-synuclein biology in Lewy body diseases
por: Kim, Woojin Scott, et al.
Publicado: (2014)

Exogenous Alpha-Synuclein Evoked Parkin Downregulation Promotes Mitochondrial Dysfunction in Neuronal Cells. Implications for Parkinson’s Disease Pathology
por: Wilkaniec, Anna, et al.
Publicado: (2021)

Exploring the Impact of PARK2 Mutations on the Total and Mitochondrial Proteome of Human Skin Fibroblasts
por: Zilocchi, Mara, et al.
Publicado: (2020)

Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?
por: Zaltieri, Michela, et al.
Publicado: (2015)

Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease
por: Fitzgerald, Emily, et al.
Publicado: (2019)

Imaging of α-Synuclein Aggregates in a Rat Model of Parkinson’s Disease Using Raman Microspectroscopy
por: Sevgi, Fide, et al.
Publicado: (2021)

BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62
por: Friesen, Erik L., et al.
Publicado: (2020)

Editorial: Oxidative stress link associated with mitochondrial bioenergetics: relevance in cell aging and age-related pathologies
por: Kalra, Rajkumar Singh, et al.
Publicado: (2023)

Alpha-Synuclein as a Pathological Link Between Chronic Traumatic Brain Injury and Parkinson's Disease
por: Acosta, Sandra A, et al.
Publicado: (2015)

Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson’s Disease Etiopathology
por: Wilkaniec, Anna, et al.
Publicado: (2018)

Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD
por: Esteves, A. R., et al.
Publicado: (2011)

Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
por: Indrieri, Alessia, et al.
Publicado: (2020)

Gastrointestinal Biopsies for the Diagnosis of Alpha-Synuclein Pathology in Parkinson's Disease
por: Cersosimo, Maria Graciela
Publicado: (2015)

Mitochondrial dysfunction in inflammatory bowel disease
por: Novak, Elizabeth A., et al.
Publicado: (2015)

Mitochondrial Function and Dysfunction in Dilated Cardiomyopathy
por: Ramaccini, Daniela, et al.
Publicado: (2021)

Comparative Studies in the A30P and A53T α-Synuclein C. elegans Strains to Investigate the Molecular Origins of Parkinson's Disease
por: Perni, Michele, et al.
Publicado: (2021)

Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities
por: Prasuhn, Jannik, et al.
Publicado: (2021)

Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson’s Disease
por: Shen, Ning, et al.
Publicado: (2019)

RUNX1 Mutations in Inherited and Sporadic Leukemia
por: Bellissimo, Dana C., et al.
Publicado: (2017)

Dysfunctional mitochondrial bioenergetics and the pathogenesis of hepatic disorders
por: Auger, Christopher, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_t0sl2el5s8j7tdra5ol0cf55mj